Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

⟵ Back to Search Results

Beigene Study ID

BGB-A317-3111-10188-101

ClinicalTrials.gov ID

NCT04282018

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Sex: All

Age: 18 Years / N/A

No Study Documents